Los Angeles: For the first time in history, a patient has begun a cancer -changing virus, it is expected that a new cancer treatment will be revealed.
Experts have converted an oncostic or cancer virus to genetic levels and mixed it in a drug called CF33-HNIS, but its simple name is vaccine.
.jpg)
The CF33 HNIS is a changed virus of measles that does not cause the disease, but increases its numbers by entering cancer cells and even tearing down the affected cells. Now there are hundreds of thousands of new viruses that act as anti -agitators and attack cancer cells around the body by stimulating their defense system. Thus it works in two.
Animals have received encouraging results by testing them, but no human being has been tested so far. Now the City of Hope Cancer Center in Los Angeles and the Australian Amoogen Company has announced the first test on humans.
In the first phase, 100 people will be assessed by this method of treatment. However, Central scientist Denning Lee said that oncostic cells can increase the body's immune system against cancer and that there are hardly effective than aminothhritis. They hope that the CF33 HNIS will help to treat patients.
All 100 persons involved in the experiment have solid and large boils of cancer in the body, which have first treated two standard treatment. All patients will be vaccinated directly in the meat or vein. In the meantime, a team of doctors will inspect all patients.
The 'Human Sodium Iodide Importer' or HNIS involved in the drug is a kind of protein that will help in the body's increasing number of viral, cancer cells, and other routines.
But even more importantly, the effects of the medicine and the negative risks of the patient should be detected, which is also the first purpose of scientists.
According to scientists, the drug test will continue for two years.
